These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. Chatellier G; Lacomblez L BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926 [TBL] [Abstract][Full Text] [Related]
6. Confusion, dementia and anticholinergics in Parkinson's disease. de Smet Y; Ruberg M; Serdaru M; Dubois B; Lhermitte F; Agid Y J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1161-4. PubMed ID: 7161613 [TBL] [Abstract][Full Text] [Related]
7. Tetrahydroaminoacridine and Alzheimer's disease. Levy R Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126 [No Abstract] [Full Text] [Related]
8. Tetrahydroaminoacridine in Alzheimer's disease. Walsh AC BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129 [No Abstract] [Full Text] [Related]
9. Tetrahydroaminoacridine and lecithin for Alzheimer's disease. N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447 [No Abstract] [Full Text] [Related]
10. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?]. Drukarch B; Stoof JC Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771 [No Abstract] [Full Text] [Related]
11. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol. Herink J; Koupilová M; Hrdina V Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124 [No Abstract] [Full Text] [Related]
12. Homatropine-associated confusion in an elderly patient. Falbe WJ; Boyd DL J Am Geriatr Soc; 1988 Jul; 36(7):649. PubMed ID: 3385118 [No Abstract] [Full Text] [Related]
13. Tetrahydroaminoacridine in HIV infections. The THA Study Group. Fredj G; Dietlin F; Fredj D; Schwarzenberg L; Jasmin C; Meyer P; Misset JL Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):408-10. PubMed ID: 2793276 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease. Kumar V; Becker RE Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):478-85. PubMed ID: 2684868 [TBL] [Abstract][Full Text] [Related]
15. Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence. Francis PT; Bowen DM Can J Neurol Sci; 1989 Nov; 16(4 Suppl):504-10. PubMed ID: 2572313 [TBL] [Abstract][Full Text] [Related]
16. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Summers WK; Tachiki KH; Kling A Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104 [TBL] [Abstract][Full Text] [Related]
17. The use of tacrine for tardive dyskinesia. Ingram NA; Newgreen DB Am J Psychiatry; 1983 Dec; 140(12):1629-31. PubMed ID: 6650699 [TBL] [Abstract][Full Text] [Related]
18. Tacrine in Alzheimer's disease. Davies B; Andrewes D; Stargatt R; Ames D; Tuckwell V; Davis S Lancet; 1989 Jul; 2(8655):163-4. PubMed ID: 2567933 [No Abstract] [Full Text] [Related]
19. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study. Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720 [TBL] [Abstract][Full Text] [Related]
20. [Overdose of anticholinergic agents and confusional syndrome]. Choulot JJ; Mensire A; Saint Martin J Ann Pediatr (Paris); 1989 Dec; 36(10):714. PubMed ID: 2624388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]